New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
09:15 EDTRGSE, INCY, CLVS, AAP, GTIV, CSCO, XONE, SRNE, KSS, LIQD, WMT, AVGO, VOXX, PLUG, BMY, KND, CAVMOn The Fly: Pre-market Movers
HIGHER: Cisco (CSCO), up 8% after reporting better than expected third quarter results. Avago (AVGO) is also up 0.6% and Cavium (CAVM) is up 3% following Cisco's report... Gentiva Health (GTIV), up 60% after Kindred Healthcare (KND) proposes to acquire the company for $14.00 per share in cash and stock... Advance Auto Parts (AAP), up 3.3% after raising its outlook... Clovis (CLVS), up 7.7% after reporting drug data at ASCO conference... Plug Power (PLUG), up 2.4% following upgrade at Cowen. DOWN AFTER EARNINGS: Wal-Mart (WMT), down 2.9%... Kohl's (KSS), down 3.6%... ExOne (XONE), down 15%... Real Goods Solar (RGSE), down 13.7%. ALSO LOWER: Bristol-Myers (BMY), down 4% following downgrade at BMO Capital citing last nights' ASCO abstracts discussing disappointing Nivo-Yervfoy combination data... VOXX International (VOXX), down 25% after downgraded at B. Riley following worse than expected Q4 results... Sorrento Therapeutics (SRNE), down 21% after 4.765M share secondary stock offering priced at $5.25... Incyte (INCY), down 9.7% after an abstract regarding a Phase 2 study of its pancreatic cancer drug was posted at ASCO... Liquid Holdings (LIQD), down 43.5% after its 32M share secondary priced at $1.25.
News For CSCO;CAVM;WMT;GTIV;KND;LIQD;AAP;BMY;KSS;CLVS;PLUG;SRNE;INCY;VOXX;XONE;RGSE;AVGO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
March 17, 2015
10:00 EDTXONEOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:25 EDTXONE, PLUGOn The Fly: Pre-market Movers
Subscribe for More Information
07:40 EDTXONEExOne guidance 'pretty good,' says Oppenheimer
Subscribe for More Information
07:06 EDTPLUGPlug Power reports Q4 EPS (4c), consensus (4c)
Subscribe for More Information
05:39 EDTXONEExOne downgraded to Market Perform from Outperform at FBR Capital
Subscribe for More Information
05:32 EDTINCYIncyte announces Novartis receives EC approval for Jakavi
Incyte (INCY) announced that Novartis (NVS) received approval from the European Commission for Jakavi for the treatment of adult patients with polycythemia vera, or PV, who are resistant to or intolerant of hydroxyurea. Jakavi is the first targeted treatment approved by the European Commission for these patients. Under the Incyte-Novartis Collaboration and License Agreement signed in 2009, Novartis received exclusive development and commercialization rights to ruxolitinib outside of the United States for all hematologic and oncologic indications, and sells ruxolitinib under the name Jakavi. Ruxolitinib is marketed by Incyte in the United States as Jakafi. Jakafi is approved by the FDA for treatment of people with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea. Jakafi is also indicated for treatment of people with intermediate or high-risk myelofibrosis, or MF, including primary MF, post–polycythemia vera MF, and post–essential thrombocythemia MF.
March 16, 2015
19:00 EDTXONEOn The Fly: After Hours Movers
Subscribe for More Information
17:40 EDTRGSERGS Energy files to delay Form 10-K
Subscribe for More Information
17:18 EDTXONEExOne sees FY15 revenue $58M-$66M, consensus $61.77M
Subscribe for More Information
17:17 EDTXONEExOne reports Q4 EPS (50c), may not compare to consensus (5c)
Subscribe for More Information
15:26 EDTPLUGNotable companies reporting before tomorrow's open
Subscribe for More Information
11:03 EDTAVGOAvago ships over 1M VCSEL channels
Subscribe for More Information
10:21 EDTCSCOVicor says SynQor power converter claims held to be invalid
In a unanimous decision, the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., on March 13 issued a ruling invalidating key claims of a power converter patent asserted by SynQor Inc. against Vicor Corporation (VICR) and Cisco Systems (CSCO) in litigation currently pending in the United States District Court for the Eastern District of Texas. Reversing a decision of the United States Patent and Trademark Office, the Federal Circuit agreed with Vicor that prior art anticipated certain claims of SynQor's 7,072,190 patent and ordered the USPTO to reconsider the obviousness of the remaining claims. Commenting on the decision, Dr. Patrizio Vinciarelli, Vicor's CEO, stated, "The Federal Circuit decision turns the tables on SynQor, which resorted to attacking competitors and customers with bogus intellectual property after failing in the marketplace with its inferior bus converters. As a company founded on innovation, Vicor respects legitimate IP interests of others. However, Vicor will confront abusive IP litigation where, as here, illegitimate claims are asserted to suppress competition from superior products known not to infringe." Vicor has asserted counterclaims against SynQor. In its counterclaims, Vicor seeks damages for unfair and deceptive trade practices and tortious interference engaged in by SynQor as part of its campaign to discourage customers from using Vicor's superior products so as to monopolize the bus converter market. Vicor will hold SynQor, and its principals, accountable for damages they have intentionally caused.
10:02 EDTAVGOOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AmerisourceBergen (ABC) upgraded to Buy from Neutral at UBS... Avago (AVGO) upgraded to Buy from Neutral at DA Davidson... Francesca's (FRAN) upgraded to Buy at Janney Capital... Goldcorp (GG) upgraded to Overweight from Neutral at HSBC... Jabil Circuit (JBL) upgraded to Buy from Hold at Cross Research... JetBlue (JBLU) upgraded to Outperform at Raymond James... King Digital (KING) upgraded to Overweight from Neutral at JPMorgan... L.B. Foster (FSTR) upgraded to Outperform from Neutral at Macquarie... NextEra Energy (NEE) upgraded to Buy from Hold at Deutsche Bank... Petrobras Argentina (PZE) upgraded to Buy from Neutral at BofA/Merrill... Qorvo (QRVO) upgraded to Buy from Neutral at DA Davidson... Randgold (GOLD) upgraded to Overweight from Neutral at HSBC... Royal Gold (RGLD) upgraded to Overweight from Neutral at HSBC... Seagate (STX) upgraded at Needham... Standex (SXI) upgraded to Buy from Hold at BB&T... Union Pacific (UNP) upgraded to Outperform from Neutral at Macquarie... West Corp. (WSTC) upgraded to Outperform from Neutral at RW Baird... Xilinx (XLNX) upgraded to Buy from Hold at Drexel Hamilton... YPF (YPF) upgraded to Buy from Neutral at BofA/Merrill.
09:05 EDTSRNENantWorks and Sorrento announce global collaboration to develop immunotherapies
Subscribe for More Information
07:57 EDTAVGOAvago upgraded to Buy from Neutral at DA Davidson
Subscribe for More Information
07:53 EDTXONEExOne March volatility elevated at 135 into Q4 and outlook
Subscribe for More Information
07:32 EDTCSCOUBM Tech to hold a conference
Enterprise Connect 2015 is being held in Orlando, Florida on March 16-19.
06:16 EDTWMTWal-Mart to sell Tide rival Persil in stores, WSJ reports
Subscribe for More Information
06:09 EDTCSCOStocks with implied volatility below IV index mean; CSCO QCOM
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use